Wegovy cost in October 2026: $349 a month self-pay ($199 to start)

How much is Wegovy without insurance?

Novo Nordisk sells Wegovy pens to self-paying patients at one flat price for every standard dose: $349 a month for 0.25, 0.5, 1, 1.7 or 2.4 mg, where a month is one box of four pens. The higher-strength Wegovy HD 7.2 mg pen is $399^[1].

New patients get an introductory price: $199 a month for the first two fills of 0.25 mg and 0.5 mg, through December 31, 2026^[1]. The offer terms end on that date, so expect this page to change in January.

You can pay these prices two ways: have your prescriber send the prescription to NovoCare Pharmacy for home delivery, or enroll in the Wegovy savings offer and take it to a retail pharmacy^[1]. NovoCare’s terms say self-pay prescriptions are filled by CenterWell, CoAssist (NovoCare Legacy) or BlinkRx network pharmacies and that insurance is not accepted for this program^[3].

What does the first year of Wegovy cost?

Arithmetic only, on published prices, assuming twelve monthly boxes: two intro fills at $199 plus ten fills at $349 come to $3,888. Twelve fills at the standard $349 come to $4,188. Twelve months of Wegovy HD at $399 would be $4,788. Your prescriber decides the dose schedule; these totals are not a recommendation. Compare against other options in the comparison builder.

How has the Wegovy cash price changed?

Before March 2025, Novo’s savings offer gave cash-paying patients Wegovy at $650 a month, according to Novo’s March 24, 2025 release^[4]. On March 5, 2025, Novo launched NovoCare Pharmacy at $499 a month for every dose^[5] and extended that price to retail pharmacies on March 24^[4]. On November 17, 2025, it cut the standard self-pay price from $499 to $349 and introduced the $199 first-two-months offer, originally running to March 31, 2026^[6]. On our October 19, 2026 check, the $199 offer had been extended through December 31, 2026^[1].

From $650 to $349 is a 46% drop for the standard self-pay price in under two years.

How much is Wegovy with insurance?

With commercial insurance that covers Wegovy, the savings offer lets you pay as little as $25 a month, subject to a maximum savings of $100 a month^[1]. If your plan has a high copay or doesn’t cover obesity medicines, compare that copay against the $349 self-pay price; self-pay spending generally won’t count toward your deductible^[1].

Does Medicare cover Wegovy?

Yes, for eligible patients, through the Medicare GLP-1 Bridge. Novo’s Wegovy site says eligible Medicare patients pay $50 a month for the Wegovy pen and pill, with eligibility determined by CMS^[2]. KFF reports the Bridge runs from July 1, 2026 to December 31, 2027 and requires prior authorization^[7]. Separately, Part D plans can cover GLP-1s for other FDA-approved uses such as cardiovascular risk reduction, and people already covered that way stay on their Part D plan^[7]. See the Medicare guide.

Is Wegovy cheaper through telehealth or TrumpRx?

The medicine price is the same. TrumpRx.gov lists the Wegovy pen at $199 a month against an "Original Price" of $1,349^[8], which is Novo’s new-patient intro price. Ro, Hims and Hers, WeightWatchers, LifeMD and Mochi all advertise Wegovy pens from $199^{[9][10][11][12][13]}. Novo names Costco, GoodRx, WeightWatchers, Ro, LifeMD and eMed as partners offering its self-pay prices^[6]. What differs is the membership fee each program adds; see programs.

Is compounded semaglutide the same as Wegovy?

No. Compounded drugs are made by state-licensed pharmacies or outsourcing facilities. They are not FDA-approved, are not generic versions of Wegovy, Ozempic, Zepbound or Mounjaro, and the FDA has not reviewed them for safety, effectiveness or quality. The FDA declared the semaglutide injection shortage resolved on February 21, 2025, and says semaglutide is not currently on its drug shortage list^[14]. Prices are on the compounded semaglutide cost page.